FI946043A0 - Sokeripäällysteinen farmaseuttinen annosyksikkö - Google Patents

Sokeripäällysteinen farmaseuttinen annosyksikkö

Info

Publication number
FI946043A0
FI946043A0 FI946043A FI946043A FI946043A0 FI 946043 A0 FI946043 A0 FI 946043A0 FI 946043 A FI946043 A FI 946043A FI 946043 A FI946043 A FI 946043A FI 946043 A0 FI946043 A0 FI 946043A0
Authority
FI
Finland
Prior art keywords
dosage unit
pharmaceutical dosage
sugar coated
coated pharmaceutical
sugar
Prior art date
Application number
FI946043A
Other languages
English (en)
Swedish (sv)
Other versions
FI946043A (fi
FI116035B (fi
Inventor
Haan Pieter De
Marcus Johannes Maria Deurloo
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of FI946043A0 publication Critical patent/FI946043A0/fi
Publication of FI946043A publication Critical patent/FI946043A/fi
Application granted granted Critical
Publication of FI116035B publication Critical patent/FI116035B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI946043A 1993-12-23 1994-12-22 Menetelmä sokeripäällysteisen farmaseuttisen annosyksikön valmistamiseksi FI116035B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93203645 1993-12-23
EP93203645 1993-12-23

Publications (3)

Publication Number Publication Date
FI946043A0 true FI946043A0 (fi) 1994-12-22
FI946043A FI946043A (fi) 1995-06-24
FI116035B FI116035B (fi) 2005-09-15

Family

ID=8214236

Family Applications (1)

Application Number Title Priority Date Filing Date
FI946043A FI116035B (fi) 1993-12-23 1994-12-22 Menetelmä sokeripäällysteisen farmaseuttisen annosyksikön valmistamiseksi

Country Status (16)

Country Link
US (1) US5662936A (fi)
EP (1) EP0659432B1 (fi)
JP (1) JPH07206681A (fi)
KR (1) KR100330560B1 (fi)
CN (1) CN1108929A (fi)
AT (1) ATE155039T1 (fi)
AU (1) AU685538B2 (fi)
CA (1) CA2138451C (fi)
DE (2) DE69404116T2 (fi)
DK (1) DK0659432T3 (fi)
ES (1) ES2105501T3 (fi)
FI (1) FI116035B (fi)
GR (1) GR3024817T3 (fi)
NO (1) NO305273B1 (fi)
NZ (1) NZ270228A (fi)
ZA (1) ZA949929B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
EP0792152B1 (en) * 1994-11-22 2004-04-14 Balance Pharmaceuticals, Inc. Methods of contraception
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
PT927556E (pt) * 1997-09-23 2000-12-29 Akzo Nobel Nv Unidades de dosagem de esteroides com um revestimento para selagem destes
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
MXPA02003645A (es) * 1999-10-11 2003-07-28 Ml Lab Plc Aparato suministrador de medicamento con revestimiento resistente a la humedad.
US6254888B1 (en) 2000-01-28 2001-07-03 Boehringer Ingelheim Pharmaceuticals, Inc. Method for coating pharmaceutical dosage forms
AU4278301A (en) * 2000-03-27 2001-10-08 Kyowa Hakko Kogyo Co. Ltd. Easy-to-take granule
ATE315930T1 (de) * 2000-05-18 2006-02-15 Therics Inc Einkapselung eines toxischen kerns in einen nicht-toxischen bereich in einer oralen darreichungsform
JP2002068965A (ja) * 2000-08-31 2002-03-08 Teikoku Hormone Mfg Co Ltd 単層糖衣錠及びその製造方法
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
CA2562386C (en) 2004-04-21 2014-11-18 Innovata Biomed Limited Inhaler
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
DE602005023193D1 (de) * 2004-10-15 2010-10-07 Suedzucker Ag Verbessertes trommelcoating-verfahren
JP4808453B2 (ja) * 2005-08-26 2011-11-02 株式会社荏原製作所 研磨方法及び研磨装置
JP2009509974A (ja) * 2005-09-23 2009-03-12 スレッシュオールド ファーマシューティカルズ， インコーポレイテッド 抗癌治療
CN103281913A (zh) * 2010-12-29 2013-09-04 雀巢产品技术援助有限公司 包含团聚的油粉的糖果产品
BR112014033005A2 (pt) * 2012-07-03 2017-06-27 Nestec Sa produto de confeitaria compreendendo pó oleoso aglomerado
WO2014079592A1 (en) * 2012-11-22 2014-05-30 Evonik Industries Ag Process for preparing a granulated product from a powder composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736682A (en) * 1954-10-11 1956-02-28 Victor M Hermelin Method of making a prolonged action medicinal tablet
US3576663A (en) * 1967-05-29 1971-04-27 Colorcon Coated tablet
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations

Also Published As

Publication number Publication date
EP0659432A1 (en) 1995-06-28
CN1108929A (zh) 1995-09-27
FI946043A (fi) 1995-06-24
FI116035B (fi) 2005-09-15
NO944991D0 (no) 1994-12-22
NO305273B1 (no) 1999-05-03
ES2105501T3 (es) 1997-10-16
NO944991L (no) 1995-06-26
EP0659432B1 (en) 1997-07-09
KR950016715A (ko) 1995-07-20
GR3024817T3 (en) 1998-01-30
ATE155039T1 (de) 1997-07-15
DK0659432T3 (da) 1998-02-16
DE659432T1 (de) 1997-01-30
AU8168494A (en) 1995-06-29
US5662936A (en) 1997-09-02
DE69404116T2 (de) 1997-11-13
CA2138451A1 (en) 1995-06-24
KR100330560B1 (ko) 2002-09-05
DE69404116D1 (de) 1997-08-14
CA2138451C (en) 2007-04-24
JPH07206681A (ja) 1995-08-08
ZA949929B (en) 1995-08-23
NZ270228A (en) 1995-09-26
AU685538B2 (en) 1998-01-22

Similar Documents

Publication Publication Date Title
FI946043A0 (fi) Sokeripäällysteinen farmaseuttinen annosyksikkö
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
CA2166332A1 (en) Antiglucocorticoid steroids for the treatment of anxiety disorders
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
GB9414966D0 (en) Pharmaceutical compositions for the nasal administration of antiviral agents
IL65843A (en) Pharmaceutical compositions for the treatment of depression containing 3-aza-bicyclo(3.1.0)hexane derivatives and certain novel compounds of this type
AU623805B2 (en) New use of anti-progestomimetic compounds
DK0613687T3 (da) Anvendelse af pregnanderivat til behandling af tumorer
ES2110258T3 (es) Derivados de 1,3,5(10)-estratrieno activos por via oral.
DE59010302D1 (de) R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.
ZA929879B (en) Compositions for the treatment of mammalian diseases.
MX9204815A (es) Hexahidrobenzo[f]quinolinonas y formulacion farmaceutica que las comprende.
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
ES2184285T3 (es) Compuestos farmaceuticos que contienen diclorhidrato de cinconina.
HUP9801985A3 (en) Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis
SE9303289D0 (sv) The use of inositoltrisphosphate for the preparing of medicaments
FR2757512B1 (fr) Utilisation de benzoylalkyl-1-1,2,3,6-tetrahydropyridines
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116035

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: N.V. ORGANON

Free format text: N.V. ORGANON